Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 43.25
-2.55 (-5.57%)
Jul 16, 2026, 1:45 PM CST
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 9.16 billion as of July 16, 2026. Its market cap has increased by 118.15% in one year.
Market Cap
9.16B
Enterprise Value
8.71B
Revenue
12.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
43.25
ChartMarket Cap Chart
Since April 28, 2022, Locus Cell's market cap has decreased from 9.88B to 9.16B, a decrease of -7.27%. That is a compound annual growth rate of -1.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 9.16B | 59.30% |
| Dec 31, 2025 | 5.75B | 44.14% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
| Apr 28, 2022 | 9.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gongwin Biopharm Holdings | 13.15B |
| AP Biosciences | 10.86B |
| Polaris Group | 10.75B |
| Tanvex BioPharma | 10.65B |
| PharmaEngine | 9.68B |
| Acepodia | 7.61B |
| Adimmune | 7.36B |
| Savior Lifetec | 6.61B |